Latest News and Press Releases

REDWOOD CITY, Calif., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today reported financial results for the third quarter ended September 30, 2008. The net loss for...

REDWOOD CITY, Calif., Nov. 5, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced that it will present at the Rodman & Renshaw 10th Annual Healthcare Conference...

REDWOOD CITY, Calif., Oct. 22, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced two presentations on its clinical stage hypoxia-activated prodrug, TH-302. The...

REDWOOD CITY, Calif., Oct. 13, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) announced today a clarification for shareholders regarding the current number of common shares...

REDWOOD CITY, Calif., Sept. 16, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLDD), today announced that it has initiated a Phase 1/2 clinical trial of TH-302 in combination with...

REDWOOD CITY, Calif., Sept. 9, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLDD), announced today that it has received written communication from the NASDAQ Listing...

REDWOOD CITY, Calif., Sept. 2, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLDD), today announced that its previously announced private placement of Threshold common stock and...

REDWOOD CITY, Calif., Aug. 20, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLDD) today announced the effectiveness of a reverse stock split. Effective today, every six shares of...

REDWOOD CITY, Calif., Aug. 12, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced that it has initiated a clinical trial of TH-302 in combination with various...

REDWOOD CITY, Calif., Aug. 7, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today reported financial results for the second quarter ended June 30, 2008. The net loss for the...